肝动脉栓塞化疗联合静脉化疗在胃癌肝转移中的疗效分析

目的探讨肝动脉栓塞化疗联合静脉化疗在胃癌肝转移中的疗效。方法对145例胃癌肝转移瘤行肝动脉造影,观察肝转移瘤血供情况,进行肝动脉栓塞化疗,并联合静脉化疗,评价其疗效。结果胃癌肝转移瘤血供丰富86例,有效率88.37%,中位生存期16.5个月;胃癌肝转移瘤少血供59例,有效率49.42%,中位生存期9.2个月。两组间有明显差异（P〈0.05）。结论肝动脉栓塞化疗联合静脉化疗是胃癌肝转移的有效治疗方法,富血供的胃癌肝转移瘤较少血供的胃癌肝转移瘤疗效好。

Application of Transcatheter Hepatic Arterial Chemoembolization Combined with Continues Intravenous Injection in the Treatment of Liver Metastases from Gastric Carcinoma

Objective To study the efficacy of interventional therapy combined with continues intravenous injection in liver metastases from gastric carcinoma.Methods One hundred and forty-five patients with metastases from gastric carcinoma were undergone selectivearteriography,ultraselective gastric arteriography and hepatic arteriography after chemical treatment and chemoembolization.Blood supply types of metastatic tumors of liver were observed and metastic tumors were perfused and embolized through hepatic arteries.Results In these cases there were 86 hypervascular cases with effective rate of in 88.37% ;59 hypovascular cases with effective rate 49.42%.There was signiticant difference between both types（P0.05）.The meso-life span of patients with hypervascular metastatic tumor was 16.5 months while that of patients with hypervascular metastatic tumor was 9.2 months.The meso-life span of patients with hypervascular metastatic tumor was longer obviously than that of patients with pervascular metastatic tumor（P0.05）.Conclusion Arterial periasion and arterial chemoembolization are effective in the treatment of metastatic tumors of liver from gastric cancer.The theraputic effieacy of hypervascular metastatic tumor is better than that of hypovascular metastic tumor.